FDA 483 - Waterstone Pharmaceuticals Co., Ltd. - September 29, 2021
Discuss this record with AI
Document or profile
One record shows the event. A profile shows the pattern.
Buy this document for the source file and details behind this single event.
Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.
Waterstone Pharmaceuticals Co., Ltd, an Active Pharmaceutical Ingredient manufacturer in Tianmen, Hubei, China, was cited for significant deficiencies during an FDA inspection. The inspection revealed a repeat observation regarding poorly maintained manufacturing facilities, including mold, rust, and unsanitary cleaning practices. Additionally, the firm lacked appropriate controls over computerized systems, leading to risks of data manipulation and missing analytical data.
ID · dc419c2c-8f90-4a4c-8836-531f4c39cf0b